The statistical core has extensive experience in managing and analyzing infectious disease data. The core leader has analyzed primarily herpes-related data for the last four years, and has contributed to novel work in herpes including determination of a cutoff for positivity by PCR, the impact of different observation periods and collection schedules on measurement of shedding characteristics, and potential associations of disease severity with both toll-like receptor (TLR) variants and HLA type. The data manager has 20 years of experience coordinating clinical, patient-provided, and laboratory data at the UW VRC. She has developed collaborations and procedures that facilitate the compilation and storage of cleaned, accurate data in a centralized location. We will accomplish the following four specific aims: 1) assist in the planning of experiments, including sample size calculations and study design, 2) coordinate data collection, verification and management, in collaboration with laboratories and other data collection sources, 3) perform statistical analyses and assist in interpretation of results, developing or adapting new methodology as appropriate and 4) develop new statistical methodologies as appropriate. To achieve aim 3, project-specific aims will require the implementation of statistical techniques including but not limited to: poisson regression for overdispersed data, zero-inflated models, generalized estimating equations and linear mixed models for correlated data.
Aim 4 may involve development of tools for determination of and assessment of associations with viral clearance rate following HSV2 reactivation, building on the viral dynamics literature strongly focused on HIV viral load.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI030731-22
Application #
8382102
Study Section
Special Emphasis Panel (ZAI1-MMT-M)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
22
Fiscal Year
2012
Total Cost
$332,213
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ott, Mariliis; Jing, Lichen; Lorenzo, Lazaro et al. (2017) T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis. Pediatr Infect Dis J 36:741-744
Matrajt, Laura; Gantt, Soren; Mayer, Bryan T et al. (2017) Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep 7:13105
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2017) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect :
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Hensel, Michael T; Peng, Tao; Cheng, Anqi et al. (2017) Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol 91:
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Looker, Katharine J; Magaret, Amalia S; May, Margaret T et al. (2017) First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 5:e300-e309
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2017) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol :

Showing the most recent 10 out of 340 publications